Improved HSV-1 Amplicon Packaging System Using ICP27-Deleted, Oversized HSV-1 BAC DNA
Herpes simplex virus type 1 (HSV-1) has several unique features that make it a promising candidate for gene transfer vehicles. These include: i) a pantropic viral envelope; ii) a large genome (approx 152 kb), which confers its large transgene capacity; and iii) the ability of entering a latency state in neurons with limited transcriptional activity (see refs. 1 –3 ). Moreover, HSV-1 is among the most extensively studied and characterized viruses, which has facilitated development of HSV-1-based vectors. Two distinct types of vectors, recombinant and amplicon, have been reported. Recombinant HSV-1 vectors use most of the viral genome as the vector backbone and can carry one or more gene(s) of interests inserted in place of the viral genes. On the other hand, amplicon vectors contain only the minimum cis-acting sequences from HSV-1 that are required for replication and packaging in the presence of HS V-1 helper functions in trans. In this chapter, we will describe the recent advance in packaging of helper virus-free HSV-1 amplicon vectors.
- FRET-Based Real-Time DNA Microarrays
- Selection of Targeted Mutants from a Library of Randomly Mutagenized ES Cells
- Preparation and Use of E. coli S-30 Extracts
- Application of Reverse Transcription In Situ PCR in Cancer Analysis
- Using Nuclear Run-On Transcription Assays in RNAi Studies
- Minimization of the Escherichia coli Genome Using the Tn5-Targeted Cre/loxP Excision System
- Methods for Noninvasive Monitoring of Muscle Fiber Survival with an AAV Vector Encoding the mSEAP Reporter Gene
- ENU Mutagenesis to Generate Genetically Modified Rat Models
- PCR Detection of Toxoplasma gondii in Human Fetal Tissues
- Putting the Invader Assay to Work: Laboratory Application and Data Management